Civic Intelligence

Neuromuscular Study Group Inc.

990 • Fiscal year 2016 • EIN 47-4456205

Jan 01, 2016 to Dec 31, 2016

Kansas City, KS
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Liabilities / Revenue

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Net Margin

71st percentile

15%

Higher net margin than 71% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

100th percentile

3237000%

Faster asset growth than 100% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2015 to 2016

Assets

Up

$32,371

Up $32,370 (+3237000%) from 2015

Net Assets

$32,371

No earlier filing loaded for comparison.

Liabilities

Flat

$0

Flat from 2015

Revenue

Up

$213,854

Up $213,854 from 2015

Expenses

Up

$181,483

Up $181,483 from 2015

Net Income

Up

$32,371

Up $32,371 from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2015: $1Liabilities 2015: $02015Assets 2016: $32,371Liabilities 2016: $0Net Assets 2016: $32,3712016Assets 2017: $77,285Liabilities 2017: $0Net Assets 2017: $77,2852017Assets 2018: $182,899Liabilities 2018: $0Net Assets 2018: $182,8992018Assets 2019: $272,554Liabilities 2019: $0Net Assets 2019: $272,5542019Assets 2020: $400,026Liabilities 2020: $0Net Assets 2020: $400,0262020Assets 2021: $636,005Liabilities 2021: $0Net Assets 2021: $636,0052021Assets 2022: $488,693Liabilities 2022: $0Net Assets 2022: $488,6932022Assets 2023: $460,644Liabilities 2023: $0Net Assets 2023: $460,6442023Assets 2024: $530,512Liabilities 2024: $0Net Assets 2024: $530,5122024

Highlighted filing

2016

Assets$32,371
Liabilities$0
Net Assets$32,371

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2016: $213,854Expenses 2016: $181,483Net Income 2016: $32,3712016Revenue 2017: $254,954Expenses 2017: $210,040Net Income 2017: $44,9142017Revenue 2018: $350,603Expenses 2018: $244,989Net Income 2018: $105,6142018Revenue 2019: $461,043Expenses 2019: $371,388Net Income 2019: $89,6552019Revenue 2020: $284,473Expenses 2020: $157,001Net Income 2020: $127,4722020Revenue 2021: $428,433Expenses 2021: $192,454Net Income 2021: $235,9792021Revenue 2022: $278,605Expenses 2022: $425,917Net Income 2022: -$147,3122022Revenue 2023: $434,016Expenses 2023: $462,062Net Income 2023: -$28,0462023Revenue 2024: $588,959Expenses 2024: $519,092Net Income 2024: $69,8672024

Highlighted filing

2016

Revenue$213,854
Expenses$181,483
Net Income$32,371
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

To advance knowledge about the cause(s), pathogenesis, epidemiology, and clinical manifestations of muscle disease and related neuromuscular disorders and to develop and implement strategies to examine promising therapeutic interventions.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings